Thrombolysis for acute stroke in Australia

Marion A Simpson, Helen M Dewey and Mark W Parsons
Med J Aust 2011; 194 (4): . || doi: 10.5694/j.1326-5377.2011.tb03788.x
Published online: 21 February 2011

In reply: We were delighted to hear of Waxman’s “miraculous” recovery, and admire the world-class standard of stroke care which was delivered at The Alfred.1 The Australian data in the Safe Implementation of Thrombolysis in Stroke (SITS) database up to 2008 included tertiary referral centres and outer metropolitan hospitals, and centres with varying experience of using recombinant tissue plasminogen activator (rt-PA) in clinical practice. There was no difference in outcomes according to experience of the treating centres. We believe that the non-trial clinical data presented in our article are a realistic indication of expected outcomes for all patients receiving thrombolysis for stroke in Australia.

  • Marion A Simpson1
  • Helen M Dewey1
  • Mark W Parsons2

  • 1 Department of Neurology, Austin Health, Melbourne, VIC.
  • 2 John Hunter Hospital, Newcastle, NSW.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.